The State of Adult ADHD Today

The State of Adult ADHD Today

The world of adult ADHD is on the cusp of a major transformation! Outdated diagnosis methods are being challenged, and new guidelines are in the works. Here’s a quick glimpse:

  • Missed Diagnoses: Current criteria often miss adult ADHD because they focus on childhood symptoms.
  • Growing Need: Many adults with lifelong ADHD are finally seeking help.
  • Training Gap: Most healthcare providers lack the training to identify and manage adult ADHD.
  • New Guidelines: APSARD is creating the first-ever guidelines specifically for adult ADHD!

These guidelines have the potential to revolutionize care, impacting everything from insurance coverage to treatment options.

Want to learn more? Read the full article:

https://www.additudemag.com/how-is-adult-adhd-diagnosed-guidelines/amp/ 

What’s race got to do with it? Informant Rating Discrepancies in neuropsychological evaluations for children with ADHD

What’s race got to do with it? Informant Rating Discrepancies in neuropsychological evaluations for children with ADHD

A recent study published in the National Institutes of Health’s National Center for Biotechnology Information investigated racial bias in how children are diagnosed with ADHD. Researchers looked at data from nearly 4,000 children undergoing neuropsychological evaluations at an outpatient clinic. The study found that teachers were more likely to rate Black children as having more inattentive symptoms and conduct problems compared to White children, regardless of whether the child was actually diagnosed with ADHD.

This study highlights the importance of considering potential racial bias in ADHD diagnoses.

To learn more about the details of this study, check out the full article here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985113/

Treating Attention-Deficit/Hyperactivity Disorder Matters

Treating Attention-Deficit/Hyperactivity Disorder Matters

Treating Attention-Deficit/Hyperactivity Disorder Matters

A new JAMA study suggests ADHD medication may lower overall mortality risk. This large Swedish study followed nearly 150,000 ADHD patients. Those taking medication consistently saw a reduced risk of death from all and unnatural causes.

Read the full article here: https://jamanetwork.com/journals/jama/fullarticle/2816107

Addressing the Ongoing ADHD Medication Shortage: APSARD Member Featured in NBC News

Addressing the Ongoing ADHD Medication Shortage: APSARD Member Featured in NBC News

2024 APSARD Election Results

The national shortage of ADHD medications, including Adderall, Ritalin, Focalin, and Vyvanse, continues to impact millions of individuals and their families. In response, a member of APSARD, was recently featured in an NBC News article discussing the challenges and potential solutions.

Read the full article here: https://www.nbcnews.com/now/video/patients-and-families-frustrated-with-years-long-adhd-drug-shortage-203743301950

Millions Face Challenges Obtaining ADHD Medication Due to Ongoing Shortage

Millions Face Challenges Obtaining ADHD Medication Due to Ongoing Shortage

2024 APSARD Election Results

The storm of the Adderall shortage hasn’t subsided, leaving millions, including children with ADHD, facing continued difficulties obtaining their medication. This ongoing crisis, fueled by increased demand and manufacturing delays, forces families to scramble each month to secure the treatment they need.

Read more from the Chicago Tribune: https://www.chicagotribune.com/2024/02/12/adhd-medication-shortage/.